Last updated Nov 4, 2026
An infant with developmental regression and hypotonia has elevated lactate. MRI shows symmetric basal ganglia and brainstem lesions.
Heterogeneous: variants in more than 120 nuclear genes (autosomal recessive, autosomal dominant, or X-linked) or in mtDNA genes (about 30% of cases, maternal or de novo) that impair mitochondrial energy generation
- SURF1, MT-ATP6, many others
Leigh syndrome spectrum is a progressive neurodegenerative disorder caused by failing mitochondrial energy generation. The causative genes converge on a few functions: respiratory chain complexes I to V, pyruvate metabolism, cofactors (coenzyme Q10, lipoic acid, thiamine, biotin), mtDNA maintenance, and mitochondrial translation. Tissues with high energy demand suffer most, and decompensation often follows an illness, fast, or surgery. The result is symmetric necrotic lesions with demyelination and gliosis in the basal ganglia and brain stem, regression, and lactate in blood and CSF; brain stem lesions explain the apnea and irregular breathing.
- Variants in SURF1 (autosomal recessive) cause complex IV (cytochrome c oxidase) deficiency; SURF1 accounts for about half of complex IV-deficient Leigh syndrome and about 30% of nuclear cases, and hypertrichosis points to it.
- Variants in MT-ATP6 (ATP synthase, complex V) act through heteroplasmy: m.8993T>G above 90% typically gives Leigh syndrome, 70% to 90% the milder NARP.
Finding the gene matters because a few causes have targeted therapy: biotin and thiamine for thiamine transporter-2 deficiency, biotin for biotinidase deficiency, coenzyme Q10 for primary coenzyme Q10 deficiency, and the ketogenic diet for pyruvate dehydrogenase deficiency.
Part of pyruvate oxidation and the respiratory chain.
Mitochondrial energy production (pyruvate oxidation, the Krebs cycle, and oxidative phosphorylation).
pyruvate → pyruvate dehydrogenase complex → acetyl-CoA → Krebs cycle → NADH, FADH2 → respiratory chain complexes I to IV (the block in most cases; complex IV with SURF1) → ATP synthase, complex V (the block with MT-ATP6) → ATP
- Accumulates: lactate in blood and CSF, with a lactate peak on MR spectroscopy; glycine when the defect is in lipoic acid synthesis.
- Missing: ATP in tissues with high energy demand; the lesions fall in the basal ganglia and brain stem.
- Workbook: 9.I. Leigh syndrome
- Subacute necrotizing encephalomyelopathy
- Developmental regression
- Hypotonia, dystonia, ataxia
- Respiratory abnormalities
- MRI: Symmetric lesions in basal ganglia, brainstem
- Elevated lactate in blood and CSF; lactate peak on MR spectroscopy
- MRI: bilateral symmetric T2/FLAIR signal in basal ganglia and brainstem is the unifying feature
- Confirmation: molecular testing (broad nuclear + mtDNA gene panel or exome/genome); muscle biopsy with respiratory-chain enzymology when molecular testing is non-diagnostic
- Supportive: no curative therapy
- Treat acute metabolic decompensation; avoid catabolic stress (fasting, illness)
- Cofactor/vitamin cocktails (thiamine, riboflavin, coenzyme Q10) are tried, with biotin/thiamine-responsive forms the clearest benefit
- Avoid sodium valproate (mitochondrial toxicity)
SURF1 = "FouR": SURF1 is an assembly factor for Complex IV (four). "SU'RF' = 'FouR'" rearranged. SURF1 mutations cause Leigh syndrome with Complex IV (cytochrome c oxidase) deficiency.
Genetically heterogeneous: Leigh syndrome can be caused by mutations in over 100 different genes (both nuclear and mitochondrial), all converging on mitochondrial energy production. The MRI pattern of symmetric basal ganglia and brainstem lesions is the unifying feature.